{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T08:46:16Z","timestamp":1764405976028,"version":"3.46.0"},"reference-count":47,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalnutritionespen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Nutrition ESPEN"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/j.clnesp.2025.10.006","type":"journal-article","created":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:53:15Z","timestamp":1761007995000},"page":"420-426","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Body composition and phase angle as prognostic factors in adults with acute lymphoblastic leukemia"],"prefix":"10.1016","volume":"70","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9307-955X","authenticated-orcid":false,"given":"V\u00edctor Ita\u00ed","family":"Urbalejo Ceniceros","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Omar Eduardo","family":"Fernandez Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erendira Baltazar","family":"Luna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Evelin Valeria","family":"Moreno Vargas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mistral Castellanos","family":"Mares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patricia Carolina","family":"Figueroa Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-7121-0530","authenticated-orcid":false,"given":"Dana Aline","family":"P\u00e9rez Camargo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clnesp.2025.10.006_bib1","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1182\/blood.2023020794","article-title":"Diagnosis, prognostic factors, and assessment of ALL in adults: 2024 ELN recommendations from a European expert panel","volume":"143","author":"G\u00f6kbuget","year":"2024","journal-title":"Blood"},{"key":"10.1016\/j.clnesp.2025.10.006_bib2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40164-020-00170-6","article-title":"Leukemia incidence trends at the global, regional, and national level between 1990 and 2017","volume":"9","author":"Dong","year":"2020","journal-title":"Exp Hematol Oncol"},{"key":"10.1016\/j.clnesp.2025.10.006_bib3","article-title":"Disease burden, risk factors, and trends of leukaemia: a global analysis","volume":"12","author":"Huang","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.clnesp.2025.10.006_bib4","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/s41375-021-01448-2","article-title":"Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study","volume":"36","author":"Moorman","year":"2022","journal-title":"Leukemia"},{"key":"10.1016\/j.clnesp.2025.10.006_bib5","doi-asserted-by":"crossref","first-page":"5202","DOI":"10.1182\/bloodadvances.2023009754","article-title":"A modified CALGB 10403 in adolescents and young adults with acute lymphoblastic leukemia in Central America","volume":"7","author":"Rangel-Pati\u00f1o","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.clnesp.2025.10.006_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/ajh.27607","article-title":"The efficacy of pediatric-inspired regimens vs. hyper- <scp>CVAD<\/scp> in the treatment of adolescents and young adults with acute lymphoblastic leukemia: a systematic review and meta-analysis","author":"Su","year":"2025","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clnesp.2025.10.006_bib7","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1182\/hematology.2024000533","article-title":"Transplant in ALL: who, when, and how?","volume":"2024","author":"Marcoux","year":"2024","journal-title":"Hematology"},{"key":"10.1016\/j.clnesp.2025.10.006_bib8","doi-asserted-by":"crossref","DOI":"10.1200\/GO.22.00292","article-title":"Expert recommendations for the diagnosis, treatment, and management of adult B-Cell acute lymphoblastic leukemia in Latin America","author":"Basquiera","year":"2023","journal-title":"JCO Glob Oncol"},{"key":"10.1016\/j.clnesp.2025.10.006_bib9","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.3324\/haematol.2022.280638","article-title":"Measurable residual disease in acute lymphoblastic leukemia: methods and clinical context in adult patients","volume":"107","author":"Saygin","year":"2022","journal-title":"Haematologica"},{"key":"10.1016\/j.clnesp.2025.10.006_bib10","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1182\/bloodadvances.2023009976","article-title":"Effect of BMI on toxicities and survival among adolescents and young adults treated on DFCI consortium ALL trials","volume":"7","author":"Shimony","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.clnesp.2025.10.006_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-39287-z","article-title":"Body mass trajectory from diagnosis to the end of treatment in a pediatric acute lymphoblastic leukemia cohort","volume":"13","author":"Galati","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.clnesp.2025.10.006_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1158\/1055-9965.EPI-16-0439","article-title":"The obesity paradox in cancer\u2014moving beyond BMI","volume":"26","author":"Strulov","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.clnesp.2025.10.006_bib13","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity","volume":"13","author":"Rubino","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/j.clnesp.2025.10.006_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/jhn.12278","article-title":"Body composition and morphological assessment of nutritional status in adults: a review of anthropometric variables","volume":"29","author":"Madden","year":"2016","journal-title":"J Hum Nutr Diet"},{"key":"10.1016\/j.clnesp.2025.10.006_bib15","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/j.clnu.2017.06.017","article-title":"ESPEN expert group recommendations for action against cancer-related malnutrition","volume":"36","author":"Arends","year":"2017","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnesp.2025.10.006_bib16","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1016\/j.clnu.2021.01.027","article-title":"Is phase angle a valuable prognostic tool in cancer patients' survival? A systematic review and meta-analysis of available literature","volume":"40","author":"Arab","year":"2021","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnesp.2025.10.006_bib17","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1080\/01635581.2017.1367939","article-title":"Assessment and impact of phase angle and sarcopenia in palliative cancer patients","volume":"69","author":"P\u00e9rez Camargo","year":"2017","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.clnesp.2025.10.006_bib18","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3892\/etm.2023.11841","article-title":"Nutritional and prognostic value of bioelectrical phase angle as a potentially modifiable marker in acute myeloid leukemia","volume":"25","author":"Jiang","year":"2023","journal-title":"Exp Ther Med"},{"key":"10.1016\/j.clnesp.2025.10.006_bib19","doi-asserted-by":"crossref","first-page":"2403","DOI":"10.1002\/cam4.2835","article-title":"The prognostic value of standardized phase angle in adults with acute leukemia: a prospective study","volume":"9","author":"Yates","year":"2020","journal-title":"Cancer Med"},{"key":"10.1016\/j.clnesp.2025.10.006_bib20","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1182\/blood-2018-10-881961","article-title":"A pediatric regimen for older adolescents and young adults with acute lymphoblastic leukemia: results of CALGB 10403","volume":"133","author":"Stock","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.clnesp.2025.10.006_bib21","doi-asserted-by":"crossref","first-page":"v69","DOI":"10.1093\/annonc\/mdw025","article-title":"Acute lymphoblastic leukaemia in adult patients: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"27","author":"Hoelzer","year":"2016","journal-title":"Ann Oncol"},{"key":"10.1016\/j.clnesp.2025.10.006_bib22","first-page":"1","article-title":"The impact of obesity on the outcomes of adult patients with acute lymphoblastic leukemia \u2013 a single center retrospective study","volume":"11","author":"Liu","year":"2021","journal-title":"Blood Lymphat Cancer"},{"key":"10.1016\/j.clnesp.2025.10.006_bib23","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/jncimonographs\/lgz020","article-title":"Mechanisms by which obesity impacts survival from acute lymphoblastic leukemia","volume":"2019","author":"Orgel","year":"2019","journal-title":"JNCI Monograph"},{"key":"10.1016\/j.clnesp.2025.10.006_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.blre.2021.100870","article-title":"The association between excess body weight at diagnosis and pediatric leukemia prognosis: a systematic review and meta-analysis","volume":"51","author":"Galati","year":"2022","journal-title":"Blood Rev"},{"key":"10.1016\/j.clnesp.2025.10.006_bib25","doi-asserted-by":"crossref","first-page":"3932","DOI":"10.1182\/blood-2014-08-595389","article-title":"Obesity is associated with residual leukemia following induction therapy for childhood B-precursor acute lymphoblastic leukemia","volume":"124","author":"Orgel","year":"2014","journal-title":"Blood"},{"key":"10.1016\/j.clnesp.2025.10.006_bib26","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.3324\/haematol.2011.056390","article-title":"Impact of body-mass index on the outcome of adult patients with acute myeloid leukemia","volume":"97","author":"Medeiros","year":"2012","journal-title":"Haematologica"},{"key":"10.1016\/j.clnesp.2025.10.006_bib27","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1002\/cncr.34807","article-title":"Obesity in adult acute myeloid leukemia is not associated with inferior response or survival even when dose capping anthracyclines: an ECOG-ACRIN analysis","volume":"129","author":"Foran","year":"2023","journal-title":"Cancer"},{"key":"10.1016\/j.clnesp.2025.10.006_bib28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1002\/hon.2543","article-title":"Serum albumin or body mass index: which prognostic factor for survival in patients with acute myeloblastic leukaemia?","volume":"37","author":"Filliatre-Clement","year":"2019","journal-title":"Hematol Oncol"},{"key":"10.1016\/j.clnesp.2025.10.006_bib29","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/ijo.2008.11","article-title":"Accuracy of body mass index in diagnosing obesity in the adult general population","volume":"32","author":"Romero-Corral","year":"2008","journal-title":"Int J Obes"},{"key":"10.1016\/j.clnesp.2025.10.006_bib30","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/jcsm.12379","article-title":"The evolution of body composition in oncology\u2014epidemiology, clinical trials, and the future of patient care: facts and numbers","volume":"9","author":"Brown","year":"2018","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/j.clnesp.2025.10.006_bib31","doi-asserted-by":"crossref","first-page":"138","DOI":"10.3109\/10428194.2015.1136741","article-title":"Limitations of body mass index to assess body composition due to sarcopenic obesity during leukemia therapy","volume":"59","author":"Orgel","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.clnesp.2025.10.006_bib32","article-title":"The prognostic value of sarcopenia in acute myeloid leukemia patients and the development and validation of a novel nomogram for predicting survival","volume":"12","author":"Sun","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.clnesp.2025.10.006_bib33","doi-asserted-by":"crossref","first-page":"62","DOI":"10.3324\/haematol.2014.110668","article-title":"The negative impact of being underweight and weight loss on survival of children with acute lymphoblastic leukemia","volume":"100","author":"den Hoed","year":"2015","journal-title":"Haematologica"},{"key":"10.1016\/j.clnesp.2025.10.006_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2013.00049","article-title":"After the chemotherapy: potential mechanisms for chemotherapy-induced delayed skeletal muscle dysfunction in survivors of acute lymphoblastic leukaemia in childhood","volume":"4","author":"Scheede-Bergdahl","year":"2013","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.clnesp.2025.10.006_bib35","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1002\/cncr.31191","article-title":"Body composition in long-term survivors of acute lymphoblastic leukemia diagnosed in childhood and adolescence: a focus on sarcopenic obesity","volume":"124","author":"Marriott","year":"2018","journal-title":"Cancer"},{"key":"10.1016\/j.clnesp.2025.10.006_bib36","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/s00277-018-3508-1","article-title":"Prognostic impact of skeletal muscle assessed by computed tomography in patients with acute myeloid leukemia","volume":"98","author":"Nakamura","year":"2019","journal-title":"Ann Hematol"},{"key":"10.1016\/j.clnesp.2025.10.006_bib37","doi-asserted-by":"crossref","DOI":"10.1111\/apha.13516","article-title":"Pathophysiological mechanisms explaining poor clinical outcome of older cancer patients with low skeletal muscle mass","volume":"231","author":"Looijaard","year":"2021","journal-title":"Acta Physiol"},{"key":"10.1016\/j.clnesp.2025.10.006_bib38","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.3390\/cancers13153820","article-title":"Muscle-derived cytokines reduce growth, viability and migratory activity of pancreatic cancer cells","volume":"13","author":"Schwappacher","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.clnesp.2025.10.006_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188761","article-title":"Muscle-to-tumor crosstalk: the effect of exercise-induced myokine on cancer progression","volume":"1877","author":"Huang","year":"2022","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"10.1016\/j.clnesp.2025.10.006_bib40","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1007\/s12185-017-2388-9","article-title":"Sarcopenia after induction therapy in childhood acute lymphoblastic leukemia: its clinical significance","volume":"107","author":"Suzuki","year":"2018","journal-title":"Int J Hematol"},{"key":"10.1016\/j.clnesp.2025.10.006_bib41","first-page":"826","article-title":"Sarcopenic obesity in survivors of childhood acute lymphoblastic leukemia: prevalence, risk factors, and implications for cancer survivors","volume":"32","author":"Das","year":"2024","journal-title":"Support Care Cancer"},{"key":"10.1016\/j.clnesp.2025.10.006_bib42","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1097\/SPC.0000000000000382","article-title":"Preservation of muscle mass as a strategy to reduce the toxic effects of cancer chemotherapy on body composition","volume":"12","author":"Pin","year":"2018","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/j.clnesp.2025.10.006_bib43","doi-asserted-by":"crossref","first-page":"107","DOI":"10.3390\/jfmk8030107","article-title":"A bioelectrical impedance analysis in adult subjects: the relationship between phase angle and body cell mass","volume":"8","author":"Cimmino","year":"2023","journal-title":"J Funct Morphol Kinesiol"},{"key":"10.1016\/j.clnesp.2025.10.006_bib44","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1080\/01635581.2017.1299880","article-title":"Phase angle of bioelectrical impedance analysis as prognostic factor in palliative care patients at the National Cancer Institute in Mexico","volume":"69","author":"P\u00e9rez Camargo","year":"2017","journal-title":"Nutr Cancer"},{"key":"10.1016\/j.clnesp.2025.10.006_bib45","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.clnesp.2018.12.004","article-title":"Phase angle as a screening tool for mortality risk among hematopoietic stem cell transplanted adult patients","volume":"29","author":"de Souza","year":"2019","journal-title":"Clin Nutr ESPEN"},{"key":"10.1016\/j.clnesp.2025.10.006_bib46","doi-asserted-by":"crossref","first-page":"5238","DOI":"10.1016\/j.clnu.2021.07.035","article-title":"Bioelectrical impedance (BIA)-derived phase angle in adults with obesity: a systematic review","volume":"40","author":"Di Vincenzo","year":"2021","journal-title":"Clin Nutr"},{"key":"10.1016\/j.clnesp.2025.10.006_bib47","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/ajcn\/82.1.49","article-title":"Bioelectrical impedance analysis: population reference values for phase angle by age and sex","volume":"82","author":"Barbosa-Silva","year":"2005","journal-title":"Am J Clin Nutr"}],"container-title":["Clinical Nutrition ESPEN"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240545772502964X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S240545772502964X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,29]],"date-time":"2025-11-29T08:44:30Z","timestamp":1764405870000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S240545772502964X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12]]},"references-count":47,"alternative-id":["S240545772502964X"],"URL":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.10.006","relation":{},"ISSN":["2405-4577"],"issn-type":[{"type":"print","value":"2405-4577"}],"subject":[],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Body composition and phase angle as prognostic factors in adults with acute lymphoblastic leukemia","name":"articletitle","label":"Article Title"},{"value":"Clinical Nutrition ESPEN","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clnesp.2025.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 European Society for Clinical Nutrition and Metabolism. Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}